Management of infections involving implanted cardiac electrophysiologic devices

被引：3

作者：

Paulin F.L. ^{[1
]}

Gula L.J. ^{[1
]}

Yee R. ^{[1
]}

Skanes A.C. ^{[1
]}

Klein G.J. ^{[1
]}

Krahn A.D. ^{[1
]}

机构：

[1] London Health Sciences Centre University Campus, London, ON N6A 5A5

来源：

Current Treatment Options in Cardiovascular Medicine | 2008年 / 10卷 / 5期

关键词：

Endocarditis; Infective Endocarditis; Permanent Pacemaker; Cardiac Device; Lead Extraction;

D O I：

10.1007/s11936-008-0029-6

中图分类号：

学科分类号：

摘要：

Indications for cardiac electrophysiologic device implantation have expanded, and the target demographic has widened. Unfortunately, these changes have been accompanied by an increase in cardiac device-associated infections out of proportion to the increase in implantation rate. Diagnosing a cardiac device infection may be challenging because of the spectrum of clinical manifestations, ranging from isolated generator pocket pain to frank sepsis with clear evidence of endocarditis. Any component of the device may be involved, but the cornerstone of therapy remains extraction of the device and its leads along with appropriate antibiotic treatment. Given the inherent risks of lead extraction, making the correct diagnosis is paramount. This review outlines the epidemiology, pathophysiology, clinical manifestations, diagnosis, and management of cardiac device infections. © Springer Science+Business Media, LLC 2008.

引用

页码：380 / 387

页数：7

共 32 条

[1]

Voigt A., Shalaby A., Saba S., Rising rates of cardiac rhythm management device infections in the United States: 1996 through 2003, J Am Coll Cardiol, 48, pp. 590-591, (2006)

[2]

Baddour L.M., Bettmann M.A., Bolger A.F., Et al., Nonvalvular cardiovascular device-related infections, Circulation, 108, pp. 2015-2031, (2003)

[3]

Duval X., Selton-Suty C., Alla F., Et al., Endocarditis in patients with a permanent pacemaker: A 1-year epidemiological survey on infective endocarditis due to valvular and/or pacemaker infection, Clin Infect Dis, 39, pp. 68-74, (2004)

[4]

Uslan D.Z., Sohail M.R., St Sauver J.L., Et al., Permanent pacemaker and implantable cardioverter defibrillator infection: A population-based study, Arch Intern Med, 167, pp. 669-675, (2007)

[5]

Klug D., Balde M., Pavin D., Et al., Risk factors related to infections of implanted pacemakers and cardioverter-defibrillators: Results of a large prospective study, Circulation, 116, pp. 1349-1355, (2007)

[6]

Da Costa A., Lelievre H., Kirkorian G., Et al., Role of the preaxillary flora in pacemaker infections: A prospective study, Circulation, 97, pp. 1791-1795, (1998)

[7]

Chamis A.L., Peterson G.E., Cabell C.H., Et al., Staphylococcus aureus bacteremia in patients with permanent pacemakers or implantable cardioverter-defibrillators, Circulation, 104, pp. 1029-1033, (2001)

[8]

Uslan D.Z., Sohail M.R., Friedman P.A., Et al., Frequency of permanent pacemaker or implantable cardioverter-defibrillator infection in patients with gram-negative bacteremia, Clin Infect Dis, 43, pp. 731-736, (2006)

[9]

Bloom H., Heeke B., Leon A., Et al., Renal insufficiency and the risk of infection from pacemaker or defibrillator surgery, Pacing Clin Electrophysiol, 29, pp. 142-145, (2006)

[10]

Sohail M.R., Uslan D.Z., Khan A.H., Et al., Risk factor analysis of permanent pacemaker infection, Clin Infect Dis, 45, pp. 166-173, (2007)

← 1 2 3 4 →